Wall Street Zen Upgrades Generate Biomedicines (NASDAQ:GENB) to “Hold”
Generate Biomedicines (NASDAQ:GENB – Get Free Report) was upgraded by Wall Street Zen to a “hold” rating in a research note issued on Saturday. Generate Biomedicines Stock Performance Shares of Generate Biomedicines stock opened at $13.08 on Friday. Generate Biomedicines has a 12 month low of $11.00 and a 12 month high of $15.32. Generate […]
16 Mar 06:12 · The Markets Daily